Healthcare

ASX Company News: Sonic Healthcare To Acquire CBLPath

Sonic Healthcare Limited (“Sonic”) (SHL) is pleased to announce that it has reached agreement to acquire CBLPath, based in Rye Brook, Westchester County, within the New York City metropolitan are...

---

OvPlex Study Expansion of UK Collaborators

HealthLinx Limited (HTX) in collaboration with Mr Khalil Razvi, South Essex Cancer Network and Dr John Green, University of Liverpool have increased the number of sites to be involved in the United ...

---

Novogen Agrees to Sell IP

Novogen Limited (NRT; NASDAQ: NVGN) today announced that it has reached agreement in principle with its subsidiary Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical ...

---

HTX: OvPlex Licensed for Israeli Market

HealthLinx Limited (HTX) has signed an exclusive OvPlex™ license agreement with Medison Pharma Limited, a leading Israeli marketing company focused on high quality pharmaceuticals, medical device...

---

Avexa Independent Review of Company Programs

Avexa Limited (ASX.AVX) has today announced that it has engaged the bioadvisory group pty ltd to undertake the independent review of the Company’s programs. The bioadvisory group is a corporate ad...

---

HealthLinx Commences South Korea Study

HealthLinx Limited (HTX) has finalised research agreements with its collaborators in South Korea to begin the 220 patient study required for South Korea Food and Drug Administration (KFDA) approval...

---

ImpediMed Managed Care Contract

ImpediMed Limited today announced another contract with a US managed care organisation for use of its L-Dex technology as an aid in the clinical assessment of lymphoedema in female breast cancer patie...

---

ImpediMed First Managed Care Contract

ImpediMed Limited today announced its first contract with a US managed careorganisation for use of its LDex technology as an aid in the clinical assessment of lymphoedema in female breast cancer pat...

---

Immuron Successful Clinical Trial Results

Immuron (IMC) reports the successful results of an open label Phase I/II clinical trial of two oral formulations of hyper-immune bovine colostrum powder (BCP), Imm122-I and Imm124-E, for the treatme...

---

VivaGel Condom Patent

Starpharma Holdings Limited (SPL, OTCQX:SPHRY) today announced the extension of the VivaGel® patent portfolio with the first grant of its patent specifically for the VivaGel® coated condom. The...

---

Phylogica Licensing Agreement with MedImmune

Phylogica Ltd (PYC, XETRA: PH7), a public Australian drug discovery company, announced today that they have entered into an agreement with MedImmune to evaluate Phylogica’s proprietary Phylomer® ...

---

NSP Maiden $3.29m Net Profit

NuSep (NSP), a life sciences company with a 30 year heritage in biological separations and the developer of the IVF SpermSep, has produced a maiden $3.29 million net profit for the year to 30th June...

---

GIA Disclosure Document

Giaconda Limited (GIA) (the "Company") today announced that it has signed an Asset Purchase Agreement to sell its Myoconda, Heliconda and Picoconda patents to RedHill Biopharma Ltd ("RedHill"). G...

---

Sigma Pharmaceuticals Proposed Sale

Sigma and Aspen agree in principle on sale of Sigma’s Pharmaceutical Division to Aspen Price of $900 million Proceeds exceed Sigma group net debt New management able to consider new initia...

---

STI Pharmacy Pilot

Pharmaceutical and Healthcare group, Stirling Products Limited (STI) advises that a significant pilot of specialist Health Clinics within two flagship stores of one of the largest pharmacy chains in...

---

UBI: OneTouch Verio in Australia

Universal Biosensors Announces Launch of OneTouch® Verio™ in Australia by LifeScan Universal Biosensors, Inc.    (UBI) announced today that it has been informed by LifeScan (a Johnson & Jo...

---

QRX: Positive Phase 2 Proof of Concept Data

QRxPharma Announces Positive Phase 2 Proof-of-Concept Data for MoxDuo IV Pain Therapy Combination of Morphine plus Oxycodone IV Demonstrates Improved Analgesia and Tolerability Compared to IV Morphi...

---

TIS: Japanese Patent Granted

VitroGro® Patent Granted in Japan Biomedical company, Tissue Therapies Limited (TIS) has announced today that the third in the family of core VitroGro® patents, “Skin Regeneration System” has b...

---

HeartWare 2nd Quarter Results

HeartWare International, Inc. (NASDAQ: HTWR - HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failu...

---

Living Cell Technologies Receives NZ Trial Approval

LCT receives approval to expand DIABECELL® NZ Trial •NZ Minister of Health approves the addition of four patients to Phase II trial •New patients add further rigour to trial by generating...

---

Patrys Secures Funding

Patrys Limited (PAB), a company focused on the development of natural human antibodies for the treatment of cancer, announced today that it has secured up to A$15 million in funding. The funding ...

---